Option Care Health Stock: 6 Straight Green Days, Up 38%
Option Care Health (OPCH) stock has risen for 6 consecutive trading days, gaining 38.1% over that stretch. That added about $1.3 billion to the company’s market value, which now stands at about $4.7 billion. The stock closed at $31.05 on Thursday, October 8, 15.1% below its 52-week high of $36.59 and 59.1% above its low of $19.52.
The Streak Next To The S&P 500
Returns for OPCH and the S&P 500 over the streak and the periods around it, all ending Thursday, October 8 and including dividends:
| Return Period | OPCH | S&P 500 |
|---|---|---|
| 1 Day | 0.1% | -0.5% |
| 6 Days (Current Streak) | 38.1% | 1.5% |
| 1 Month (21 Trading Days) | 31.3% | 1.8% |
| 3 Months (63 Trading Days) | 43.9% | 2.8% |
| Year To Date | -2.5% | 14.4% |
| 1 Year (252 Trading Days) | 14.5% | 17.0% |
A Stock-Specific Run, Or A Market Move?
The market explains little of this: the S&P 500 gained 1.5% over the same 6 sessions, including dividends, against Option Care Health’s +38.1%. Over the past three months the stock is up 43.9%, a window that includes the streak; over the other 57 sessions of that window it was up 4.3%.
Do The Fundamentals Support The Run?
On the fundamentals, revenue grew 5.9% over the last twelve months, against a median of 8.1% for S&P 500 Health Care stocks; its operating margin is 5.9%, versus a median of 17.6%; and the stock trades at 22.7 times trailing earnings against a median of 27.0. The read is mixed: a multiple below the median on one side, revenue growth below the median and margins below the median on the other.
If you are looking for strength with more behind it than a hot tape, our Guidance Momentum screen surfaces the names where management raised its own outlook.
One Hot Stock Is A Story. Thirty Sound Ones Are A Strategy
A streak like this earns a place on your watchlist, and it also earns a question: how much of your outcome do you want depending on one company keeping this up?
The Trefis High Quality (HQ) Portfolio answers it with breadth: roughly 30 businesses picked for consistent cash generation, strong margins, and balance-sheet strength, sized and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Follow the story; invest in the strategy.